TrialHuman vaccines & immunotherapeutics2017

Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects.

Won Suk Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.